ChipMOS TECHNOLOGIES INC. - American Depositary Shares (IMOS)
Live price chart, market sentiment, and community perspectives for ChipMOS TECHNOLOGIES INC. - American Depositary Shares (NASDAQ: IMOS).
Live price chart, market sentiment, and community perspectives for ChipMOS TECHNOLOGIES INC. - American Depositary Shares (NASDAQ: IMOS).
On our trading desk, IMOS is showing explosive momentum with trailing 1-year returns topping 261%. The narrative here is fascinating: revenue and gross margin expansion to 18.0% in Q2 2026 didn't come from massive volume spikes—overall utilization only ticked up slightly to 72%—but rather from the chairman selectively raising memory OSAT prices to offset gold and substrate costs. Management noted that DRAM demand exceeds supply with visibility extending through 2026. However, we are watching the cash burn closely, as cash dropped NT$2.3 billion during this record-breaking half. Valuation metrics show a trailing P/E hovering around 75, so expectations are clearly elevated. If you're looking at market sentiment, the lack of heavy US sell-side coverage means retail and specialized forums are driving the immediate price discovery relative to Taipei analysts.
From a quantitative risk perspective, IMOS presents a classic dual-sided argument. On one hand, the financial metrics from the Form 6-K filings are undeniable: May 2026 revenue up 17.7% YoY, net profit before tax surging 171.6%, and an EPS rise of 175.0%. Q2 2026 delivered an earnings beat with a US$0.80 per basic ADS print against a US$0.64 bar. Yet, the bear case focuses on sustainability. The beat was a price-driven event, not a volume surge, and assembly utilization actually fell from 84% to 78%. Furthermore, the chairman stated a reluctance to aggressively maximize pricing on customers needing support. With a quick ratio of 1.97 and current ratio of 2.44, the balance sheet looks liquid, but volatility is a given with a 5Y monthly beta of 1.44.
When evaluating OSAT providers like ChipMOS for our technical models, understanding operational leverage is critical. In Q2 2026, revenue rose NT$447.5M sequentially while gross profit jumped NT$70.1M, meaning 83 cents of every incremental dollar dropped straight through. That is an elite operational drop-through rate, largely enabled by having 28 points of unused utilization sitting under an 18% margin that was already paid for. When discussing this name with equity research teams, candidates must highlight that memory revenue was up over 46% and DRAM specifically surged over 70%. The core technical test for analysts is separating top-line vanity metrics from the underlying input cost pass-through dynamics tied to gold and substrates.
Explore plasma cleansing, somatic organ swaps, and BCI.